109 related articles for article (PubMed ID: 15931189)
21. [Translational control by the poly(A) binding protein: a check for mRNA integrity].
Svitkin YV; Sonenberg N
Mol Biol (Mosk); 2006; 40(4):684-93. PubMed ID: 16913227
[TBL] [Abstract][Full Text] [Related]
22. Protein synthesis and its control in neuronal cells with a focus on vanishing white matter disease.
Pavitt GD; Proud CG
Biochem Soc Trans; 2009 Dec; 37(Pt 6):1298-310. PubMed ID: 19909266
[TBL] [Abstract][Full Text] [Related]
23. Diagnosing "undiagnosed" leukodystrophies: The role of molecular genetics.
Noetzel MJ
Neurology; 2004 Mar; 62(6):847-8. PubMed ID: 15037679
[No Abstract] [Full Text] [Related]
24. Where has all the white matter gone? Unraveling the mysteries of leukoencephalopathies.
Kaye EM; Moser H
Neurology; 2004 May; 62(9):1464-5. PubMed ID: 15136665
[No Abstract] [Full Text] [Related]
25. Developmental splicing deregulation in leukodystrophies related to EIF2B mutations.
Huyghe A; Horzinski L; Hénaut A; Gaillard M; Bertini E; Schiffmann R; Rodriguez D; Dantal Y; Boespflug-Tanguy O; Fogli A
PLoS One; 2012; 7(6):e38264. PubMed ID: 22737209
[TBL] [Abstract][Full Text] [Related]
26. Conversion of a normal MRI into an MRI showing a cystic leukoencephalopathy is not a known feature of vanishing white matter.
van der Knaap MS; Schiffmann R; Scheper GC
Neuropediatrics; 2007 Oct; 38(5):264. PubMed ID: 18330844
[No Abstract] [Full Text] [Related]
27. Integrin-dependent translational control: Implication in cancer progression.
Chung J; Kim TH
Microsc Res Tech; 2008 May; 71(5):380-6. PubMed ID: 18300291
[TBL] [Abstract][Full Text] [Related]
28. Peripheral neuropathy in vanishing white matter disease with a novel EIF2B5 mutation.
Federico A; Scali O; Stromillo ML; Di Perri C; Bianchi S; Sicurelli F; De Stefano N; Malandrini A; Dotti MT
Neurology; 2006 Jul; 67(2):353-5. PubMed ID: 16864840
[TBL] [Abstract][Full Text] [Related]
29. Acute neurological deterioration in ovarioleukodystrophy related to EIF2B mutations: pregnancy with oocyte donation is a potentially precipitating factor.
Peter L; Niel F; Catenoix H; Jung J; Demarquay G; Petiot P; Rudigoz RC; Boespflug-Tanguy O; Ryvlin P; Mauguière F
Eur J Neurol; 2008 Jan; 15(1):94-7. PubMed ID: 18005052
[TBL] [Abstract][Full Text] [Related]
30. Targeting the eukaryotic translation initiation factor 4E for cancer therapy.
Graff JR; Konicek BW; Carter JH; Marcusson EG
Cancer Res; 2008 Feb; 68(3):631-4. PubMed ID: 18245460
[TBL] [Abstract][Full Text] [Related]
31. Dual regulation of translation initiation and peptide chain elongation during BDNF-induced LTP in vivo: evidence for compartment-specific translation control.
Kanhema T; Dagestad G; Panja D; Tiron A; Messaoudi E; Håvik B; Ying SW; Nairn AC; Sonenberg N; Bramham CR
J Neurochem; 2006 Dec; 99(5):1328-37. PubMed ID: 17064361
[TBL] [Abstract][Full Text] [Related]
32. Intra-familial phenotypic heterogeneity in adult onset vanishing white matter disease.
Damon-Perriere N; Menegon P; Olivier A; Boespflug-Tanguy O; Niel F; Creveaux I; Dousset V; Brochet B; Goizet C
Clin Neurol Neurosurg; 2008 Dec; 110(10):1068-71. PubMed ID: 18845387
[TBL] [Abstract][Full Text] [Related]
33. Targeting translation in hypoxic tumors.
Ron D; Hinnebusch AG
ACS Chem Biol; 2006 Apr; 1(3):145-8. PubMed ID: 17163661
[TBL] [Abstract][Full Text] [Related]
34. Pi release from eIF2, not GTP hydrolysis, is the step controlled by start-site selection during eukaryotic translation initiation.
Algire MA; Maag D; Lorsch JR
Mol Cell; 2005 Oct; 20(2):251-62. PubMed ID: 16246727
[TBL] [Abstract][Full Text] [Related]
35. Peripheral neuropathy in a child with Cree leukodystrophy.
Huntsman RJ; Seshia S; Lowry N; Lemire EG; Harder SL
J Child Neurol; 2007 Jun; 22(6):766-8. PubMed ID: 17641267
[TBL] [Abstract][Full Text] [Related]
36. Translational control of nrf2 protein in activation of antioxidant response by oxidants.
Purdom-Dickinson SE; Sheveleva EV; Sun H; Chen QM
Mol Pharmacol; 2007 Oct; 72(4):1074-81. PubMed ID: 17652445
[TBL] [Abstract][Full Text] [Related]
37. Higher plant chloroplasts import the mRNA coding for the eucaryotic translation initiation factor 4E.
Nicolaï M; Duprat A; Sormani R; Rodriguez C; Roncato MA; Rolland N; Robaglia C
FEBS Lett; 2007 Aug; 581(21):3921-6. PubMed ID: 17662723
[TBL] [Abstract][Full Text] [Related]
38. MicroRNAs control translation initiation by inhibiting eukaryotic initiation factor 4E/cap and poly(A) tail function.
Humphreys DT; Westman BJ; Martin DI; Preiss T
Proc Natl Acad Sci U S A; 2005 Nov; 102(47):16961-6. PubMed ID: 16287976
[TBL] [Abstract][Full Text] [Related]
39. Clues to the mechanism of action of eIF2B, the guanine-nucleotide-exchange factor for translation initiation.
Mohammad-Qureshi SS; Jennings MD; Pavitt GD
Biochem Soc Trans; 2008 Aug; 36(Pt 4):658-64. PubMed ID: 18631136
[TBL] [Abstract][Full Text] [Related]
40. The dominant form of vanishing white matter-like leukoencephalopathy represents autosomal dominant leukodystrophy.
Ptácek LJ; Fu YH; Koeppen A
Ann Neurol; 2006 Feb; 59(2):434. PubMed ID: 16437562
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
